Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis

被引:36
|
作者
Serarslan, G [1 ]
Yilmaz, HR
Sögüt, S
机构
[1] Mustafa Kemal Univ, Fac Med, Dept Dermatol, Hatay, Turkey
[2] Mustafa Kemal Univ, Fac Med, Dept Biochem, Hatay, Turkey
[3] Suleyman Demirel Univ, Fac Med, Dept Med Biol & Genet, Isparta, Turkey
关键词
D O I
10.1111/j.1365-2230.2005.01758.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Leishmania sp. are obligate intracellular protozoa that infect and replicate within mammalian macrophages. Macrophages, neutrophils and other phagocytic cells are key components of the antimicrobial and tumoricidal immune responses. These cells are capable of generating large amounts of reactive oxygen species (ROS) and reactive nitrogen species (RNS). To examine antioxidant status and lipid peroxidation in cutaneous leishmaniasis (CL) patients, activities of two ROS scavenging enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and the levels of malondialdehyde (MDA) and nitric oxide (NO.) have been studied in serum. Blood samples were taken from CL patients before treatment (n = 27) and after the treatment (n = 18). NO. and MDA levels, SOD and GSH-Px activities were compared between untreated and treated CL patients and control subjects (n = 23). There was a significant decrease in SOD and GSH-Px activities in the CL patients (P < 0.0001). Significantly higher levels of serum MDA and NO. levels were found in CL patients, compared to controls and treated patients. It may be suggested that the overproduction of ROS and RNS results in oxidative stress and the acceleration of lipid peroxidation in CL patients, resulting from altered enzymatic antioxidant activities.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 50 条
  • [31] Serum Paraoxonase/Arylesterase Activities and Malondialdehyde Levels in Trauma Patients
    Yildirim, Abdulkadir
    Aslan, Sahin
    Ocak, Tarik
    Yildirim, Serap
    Kara, Fatih
    Sahin, Yasar Nuri
    EURASIAN JOURNAL OF MEDICINE, 2007, 39 (02): : 85 - 88
  • [32] Serum xanthine oxidase and nitric oxide synthase activities and malondialdehyde as markers of coronary ischemia during stress test
    Vythoulkas, JS
    Villiotou, VE
    Pouliopoulou, SG
    Votteas, VE
    Chronakis, EB
    Makris, TK
    Kyriakidis, MK
    Deliconstantinos, GH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 274A - 274A
  • [33] Serum levels of total antioxidant status, nitric oxide and nitric oxide synthase in minor recurrent aphthous stomatitis patients
    Zhang, Zichuan
    Zhang, Qian
    Xue, Yi
    Chen, Guang
    Wu, Zhongyin
    Fang, Huiqing
    MEDICINE, 2019, 98 (03) : e14039
  • [34] Serum nitric oxide, lipid hydroperoxide levels, nitric oxide synthase activity and total serum antioxidant capacity in patients with Parkinson's disease
    Cubukcu, H. C.
    Yurtdas, M.
    Durak, Z. E.
    Aytac, B.
    Gunes, H. N.
    Cokal, B. G.
    Yoldas, T. K.
    Durak, I.
    FEBS JOURNAL, 2016, 283 : 72 - 72
  • [35] Nitric oxide and malondialdehyde levels in healthy normotensive subjects and hypertensive patients
    Hernandez-Hernandez, R
    Armas-Padilla, MC
    Cammarata, R
    Sosa-Canache, B
    Pacheco, B
    Guerrero, J
    Carvajal, AR
    Armas-Hernandez, MJ
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 71A - 71A
  • [36] Plasma malondialdehyde and nitric oxide levels in age related macular degeneration
    Totan, Y
    Çekiç, O
    Borazan, M
    Uz, E
    Sögüt, S
    Akyol, Ö
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (12) : 1426 - 1428
  • [37] The Changes of Plasma Malondialdehyde, Nitric Oxide, and Adrenomedullin Levels in Patients with Preeclampsia
    Dikensoy, Ebru
    Balat, Ozcan
    Pence, Sadrettin
    Balat, Ayse
    Cekmen, Mustafa
    Yurekli, Muhuttin
    HYPERTENSION IN PREGNANCY, 2009, 28 (04) : 383 - 389
  • [38] Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis
    Devrim, Erdinc
    Erten, Suekran
    Erguder, Imge B.
    Namuslu, Mehmet
    Turgay, Murat
    Durak, Ilker
    MEDICAL PRINCIPLES AND PRACTICE, 2008, 17 (04) : 349 - 350
  • [39] Serum and cerebrospinal fluid excitatory amino acid, nitric oxide and cerebrospinal fluid malondialdehyde levels in West syndrome
    Kumandas, Sefer
    Poyrazoglu, Hatice G.
    Per, Huseyin
    Kuyucu, Tamer
    Gumus, Hakan
    Saraymen, Recep
    JOURNAL OF PEDIATRIC EPILEPSY, 2013, 2 (04) : 239 - 243
  • [40] Malondialdehyde and Nitric Oxide Levels in the Plasma of Patients with Advanced Laryngeal Cancer
    Seyithan Taysi
    Celil Uslu
    Fatih Akcay
    Mehmet Yavuz Sutbeyaz
    Surgery Today, 2003, 33 : 651 - 654